
The Latest: FAA grounds all flights nationwide due to communications problems
By Marcus Hayes
Advertisement · Why this ad?

HOUSTON (AP) — HOUSTON (AP) — Cerenome, Inc. (CNSY) on Friday reported a loss of $8.7 million in its third quarter. The Houston-based company said it had a loss of $1.14 per share. The developer of cell therapies posted revenue of $722,000 in the period. This story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CNSY at https://www.zacks.com/ap/CNSY More from this section Associated Press Bessent moves to a military base over safety concerns, an AP source says Nov 11, 2026 Associated Press South Korea US Military Nov 12, 2026 Associated Press Who is Colette Kress, Nvidia's interim CEO? Longtime exec takes top spot after Jensen Huang resigns Nov 12, 2026 Associated Press Bessent blames Commerce's Lutnick for not restricting Nvidia chip exports to China 6 hrs ago Inside Killeen Podcast